Kristian Reich, the Chief Scientific Officer of $MLTX, sold 72,908 shares of the company on 12-09-2025 for an estimated $1,052,062. We received data on the trade from a recent SEC filing. This was a sale of approximately 100.0% of their shares of this class of stock. Following this trade, they now own 0 shares of this class of $MLTX stock.
$MLTX Insider Trading Activity
$MLTX insiders have traded $MLTX stock on the open market 9 times in the past 6 months. Of those trades, 1 have been purchases and 8 have been sales.
Here’s a breakdown of recent trading of $MLTX stock by insiders over the last 6 months:
- BIHUA CHEN has made 0 purchases and 5 sales selling 6,499,978 shares for an estimated $46,868,184.
- KRISTIAN REICH (Chief Scientific Officer) has made 0 purchases and 2 sales selling 202,908 shares for an estimated $3,012,462.
- CATHERINE MOUKHEIBIR sold 23,500 shares for an estimated $1,146,565
- MATTHIAS BODENSTEDT (Chief Financial Officer) purchased 10,870 shares for an estimated $98,808
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$MLTX Hedge Fund Activity
We have seen 82 institutional investors add shares of $MLTX stock to their portfolio, and 100 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CORMORANT ASSET MANAGEMENT, LP removed 6,499,978 shares (-76.5%) from their portfolio in Q3 2025, for an estimated $46,604,842
- FMR LLC removed 5,003,617 shares (-87.3%) from their portfolio in Q3 2025, for an estimated $35,875,933
- AVORO CAPITAL ADVISORS LLC removed 2,150,000 shares (-51.8%) from their portfolio in Q3 2025, for an estimated $15,415,500
- PRICE T ROWE ASSOCIATES INC /MD/ removed 1,790,276 shares (-68.5%) from their portfolio in Q3 2025, for an estimated $12,836,278
- CITADEL ADVISORS LLC removed 1,624,707 shares (-97.1%) from their portfolio in Q3 2025, for an estimated $11,649,149
- ADAGE CAPITAL PARTNERS GP, L.L.C. added 1,500,000 shares (+inf%) to their portfolio in Q3 2025, for an estimated $10,755,000
- BALYASNY ASSET MANAGEMENT L.P. added 1,276,065 shares (+301.5%) to their portfolio in Q3 2025, for an estimated $9,149,386
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$MLTX Analyst Ratings
Wall Street analysts have issued reports on $MLTX in the last several months. We have seen 5 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 11/21/2025
- Citigroup issued a "Sell" rating on 10/29/2025
- Guggenheim issued a "Buy" rating on 09/30/2025
- Needham issued a "Buy" rating on 09/30/2025
- Wedbush issued a "Outperform" rating on 09/30/2025
- Goldman Sachs issued a "Buy" rating on 08/06/2025
To track analyst ratings and price targets for $MLTX, check out Quiver Quantitative's $MLTX forecast page.
$MLTX Price Targets
Multiple analysts have issued price targets for $MLTX recently. We have seen 8 analysts offer price targets for $MLTX in the last 6 months, with a median target of $20.0.
Here are some recent targets:
- Raghuram Selvaraju from HC Wainwright & Co. set a target price of $26.0 on 11/21/2025
- Samantha Semenkow from Citigroup set a target price of $5.0 on 10/29/2025
- Serge Belanger from Needham set a target price of $20.0 on 09/30/2025
- Yun Zhong from Wedbush set a target price of $18.0 on 09/30/2025
- Yatin Suneja from Guggenheim set a target price of $20.0 on 09/30/2025
- Julian Harrison from BTIG set a target price of $85.0 on 09/29/2025
- Brian Abrahams from RBC Capital set a target price of $10.0 on 09/29/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
